newsfilter
← Latest News
GlobeNewswire·

Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

October 13, 2026 Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP Update on expected timing of pre-specified futility analysis and database lock